Earnshaw, Stephanie R.; McDade, Cheryl L.; Black, Libby K. - In: PharmacoEconomics 28 (2010) 6, pp. 489-505
Background: Although 5-alpha reductase inhibitors (5ARIs) have demonstrated that they reduce the risk of prostate cancer (PCa), they have not demonstrated cost effectiveness in the patient populations in which they have been examined. Objective: A decision-analytic model was created to explore...